Stage Iiib Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Stage Iiib Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative [Phase 2, Phase 3]
A phase 2/3 trial evaluating the addition of radiation therapy to standard immunotherapy with or without chemotherapy for PD-L1–negative adv…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer [Phase 3]
Phase 3 clinical trial update describing a study comparing treatment given before versus after surgery in patients with resectable stage II …
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Peripheral Blood ETASTs for Predicting Efficacy of Chemoimmunotherapy in NSCLC
A clinical trial to evaluate whether peripheral blood ETASTs can predict the efficacy of chemoimmunotherapy in non-small cell lung cancer. T…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC [Phase 2]
This is a Phase 2 neoadjuvant trial of SBRT followed by sintilimab plus chemotherapy for N3-positive locally advanced non-small cell lung ca…
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO) [Phase 2]
This document reports a Phase 2 clinical trial update examining atezolizumab in combination with induction chemotherapy and radiotherapy for…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-21Clinical Trial Update: Efficacy and Safety of Ensartinib in Neoadjuvant Therapy for Stage IIA - IIIB (Operable or Potentially Operable) ALK-Positive Lung Adenocarcinoma ：A Multicenter, Real-World Clinical Study [Phase 4]
Phase 4 multicenter real-world study evaluating the efficacy and safety of ensartinib as neoadjuvant therapy for stage IIA-IIIB ALK-positive…